Asthma exacerbations on benralizumab are largely non‐eosinophilic
Sophie M. Poznanski, Manali Mukherjee, Nan Zhao, Chynna Huang, Katherine Radford, Ali A. Ashkar, Parameswaran Nair
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
BenralizumabAsthmaMedicineAsthma exacerbationsContent (measure theory)Intensive care medicineImmunologyMepolizumabEosinophilMathematicsMathematical analysisAsthma and respiratory diseasesEosinophilic Disorders and SyndromesIL-33, ST2, and ILC Pathways